Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as amifostine, work in different ways to stop the
growth of cancer cells, either by killing the cells or by stopping them from dividing.
PURPOSE: This phase II trial is studying how well amifostine works in treating young patients
with newly diagnosed de novo myelodysplastic syndromes.